Compass Therapeutics, Inc.
CMPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $43 | $24 | $35 | $145 |
| Short-Term Investments | $83 | $128 | $152 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $1 | $8 | $3 |
| Total Curr. Assets | $133 | $154 | $195 | $147 |
| Property Plant & Equip (Net) | $7 | $3 | $5 | $6 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $0 | $0 |
| Total NC Assets | $8 | $3 | $5 | $7 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $140 | $157 | $200 | $154 |
| Liabilities | – | – | – | – |
| Payables | $2 | $4 | $3 | $1 |
| Short-Term Debt | $0 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $3 | $12 | $9 |
| Total Curr. Liab. | $9 | $8 | $16 | $11 |
| LT Debt | $6 | $1 | $2 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $6 | $1 | $2 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $2 | $3 | $4 |
| Total Liabilities | $15 | $8 | $18 | $14 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$365 | -$315 | -$273 | -$234 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $490 | $464 | $455 | $374 |
| Total Equity | $125 | $149 | $182 | $140 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $140 | $157 | $200 | $154 |
| Net Debt | -$37 | -$22 | -$32 | -$140 |